• 519 days Will The ECB Continue To Hike Rates?
  • 520 days Forbes: Aramco Remains Largest Company In The Middle East
  • 521 days Caltech Scientists Succesfully Beam Back Solar Power From Space
  • 921 days Could Crypto Overtake Traditional Investment?
  • 926 days Americans Still Quitting Jobs At Record Pace
  • 928 days FinTech Startups Tapping VC Money for ‘Immigrant Banking’
  • 931 days Is The Dollar Too Strong?
  • 931 days Big Tech Disappoints Investors on Earnings Calls
  • 932 days Fear And Celebration On Twitter as Musk Takes The Reins
  • 934 days China Is Quietly Trying To Distance Itself From Russia
  • 934 days Tech and Internet Giants’ Earnings In Focus After Netflix’s Stinker
  • 938 days Crypto Investors Won Big In 2021
  • 938 days The ‘Metaverse’ Economy Could be Worth $13 Trillion By 2030
  • 939 days Food Prices Are Skyrocketing As Putin’s War Persists
  • 941 days Pentagon Resignations Illustrate Our ‘Commercial’ Defense Dilemma
  • 942 days US Banks Shrug off Nearly $15 Billion In Russian Write-Offs
  • 945 days Cannabis Stocks in Holding Pattern Despite Positive Momentum
  • 946 days Is Musk A Bastion Of Free Speech Or Will His Absolutist Stance Backfire?
  • 946 days Two ETFs That Could Hedge Against Extreme Market Volatility
  • 948 days Are NFTs About To Take Over Gaming?
How The Ultra-Wealthy Are Using Art To Dodge Taxes

How The Ultra-Wealthy Are Using Art To Dodge Taxes

More freeports open around the…

What's Behind The Global EV Sales Slowdown?

What's Behind The Global EV Sales Slowdown?

An economic slowdown in many…

  1. Home
  2. Markets
  3. Other

SPX: Compressing Between Resistance & Support

On Wednesday, SPX opened sharply higher on the better than expected CPI report, although the core rate was in-line. SPX reached about 1,373 before pulling-back sharply. The strong open may have been a "blow-off top," and a bearish head & shoulders (on 15-minute chart) may have been created with the right shoulder at roughly 1,370 and the neckline at 1,357. Several weeks ago, SPX created a bullish inverse head & shoulders (on 15-minute chart) with the neckline at 1,338.

Over the past three days, SPX has traded entirely above the monthly upper Bollinger Band, currently 1,361. The 10-day MA, currently 1,362, has generally held for a month and the 20-day MA, currently 1,351, has generally held for three months. Both MAs have risen sharply. Consequently, SPX is being compressed between 1,370 and the rising 10-day MA. Given some short-term technical indicators are severely overbought, it's likely the compression will result in a move to the downside.

There are three possible scenerios. If the rally continues, there's a multi-year resistance level about 1,400. However, SPX will need to trade well above the monthly upper Bollinger Band, at levels not reached in 10-years, since the middle of the bubble boom. If there's a consolidation, SPX will fall below the 10-day MA, perhaps bounce initially off the 20-day MA, with further significant support levels at 1,338 and 1,326. Initial resistance is 1,370. SPX will then either rally, e.g. about 1,400, or fall, e.g. below 1,300. If there's a correction, support levels will turn into resistance levels through steep falls and volatile downtrends. First major support is 1,290.

Economic data and oil prices will largely determine SPX direction. Last week, the PPI core rate was reported much higher than expected, although the CPI core rate was in-line. Consequently, SPX may discount, over the next few weeks, higher PPI and CPI core rates in next month's report. Oil closed at 56.82 Friday. If oil falls and stabilizes around 50, that may be market bullish, or if oil rises and stabilizes around 60, that may be market bearish. I suspect, a consolidation will take place through the first week of November and then a correction will take place, since intermediate-term technical indicators are overbought. Nonetheless, I wouldn't rule out a rise to about 1,400 in early-November and a fall below 1,300 in late-November.

 

Back to homepage

Leave a comment

Leave a comment